The Trans-Pacific Partnership: A Threat To Global Health?
By Deane Marchbein
Source: Health Affairs
May 22, 2015
Lost in the political discussions over the passage of the Trans-Pacific Partnership (TPP)a trade agreement currently being negotiated in secret between the U.S. and 11 other Pacific-Rim nationsis the very real negative impact it would have on global health.
Doctors Without Borders/Médecins Sans Frontières (MSF) works in over 60 countries, and our medical teams rely on access to affordable medicines and vaccines. We are deeply concerned that the TPP, in its current form, will lock-in high, unsustainable drug prices, block or delay the availability of affordable generic medicines, and price millions of people out of much-needed medical care.
The public health repercussions of this deal could be massive. The negotiating countries represent at least 700 million people, and U.S. negotiators refer to the TPP as a blueprint for future trade deals. The TPP attempts to rewrite existing global trade rules and would dismantle legal flexibilities and protections afforded for public health.
We are told that the only way to ensure that people receive the medicines they need is by increasing intellectual property provisions, such as those encapsulated in the TPP. In reality, the existing monopoly-based innovation system that the TPP is attempting to standardize has left us with more patents and fewer medical breakthroughs.
The most recent and dramatic example of this failure in innovation played out just last year, when Ebola raged through West Africa. Doctors Without Borders and other global health actors were ill-equipped to fight a disease that was identified 40 years ago but for which there are still no adequate diagnostics, treatments, or vaccines.
Full article:
https://zcomm.org/znetarticle/the-trans-pacific-partnership-a-threat-to-global-health/